Author:
Horowitz Mary M.,Confer Dennis L.
Abstract
Abstract
Donation of hematopoietic stem cells, either through bone marrow or peripheral blood collection, is a generally safe procedure for healthy donors. Serious adverse events are uncommon and death is exceedingly rare. Nevertheless, all donors must be carefully evaluated and fully informed prior to donation. This should be done by clinicians having good understanding of the potential physical and psychological complications of donation and the factors that may increase these risks. Additionally, donors and graft products must be evaluated for the potential to transmit infections and other diseases to the recipient and to satisfy an increasing number of national and international regulatory requirements. Donors must be able to provide informed consent without coercion or pressure. Special attention to the clinical, psychological and social needs of pediatric donors is necessary.
Publisher
American Society of Hematology
Reference39 articles.
1. Bakken R, van Walreaven A-M, Egeland T. Donor commitment and patient needs. Bone Marrow Transplant. 2004;33:225–230.
2. Human cells, tissues, and cellular and tissue-based products; donor screening and testing, and related labeling. Fed Regist. 2005;70(100):29949–29952.
3. Foundation for the Accreditation of Cellular Therapy. Standards for Hematopoietic Progenitor Cell Collection, Processing & Transplantation. (2nd ed.) Omaha: Foundation for the Accreditation of Cellular Therapy (FACT); 2004.
4. National Marrow Donor Program. National Marrow Donor Program Standards, 18th Edition. Minneapolis: National Marrow Donor Program; 2002.
5. Strasser SI, McDonald GB. Hepatitis viruses and hematopoietic cell transplantation: a guide to patient and donor management. Blood. 1999;93:1127–1136.
Cited by
55 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献